Melanocytic tumors express connexin 43 but not 26: Immunohistochemical analysis with potential significance in melanocytic oncogenesis

American Journal of Dermatopathology

Volumn 35, Issue 8, 2013, Pages 813-817

  Sargen, Michael R ^a   Gormley, Rachel H ^a   Pasha, Terri L ^a   Yum, Sabrina ^b   Acs, Geza ^c   Xu, Xiaowei ^a   Zhang, Paul J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Connexin 26; Connexin 43; Gap junctions; Immunohistochemistry; Melanocytic oncogenesis; Melanoma; Nevi

Indexed keywords

CONNEXIN 26; CONNEXIN 43; POLYCLONAL ANTIBODY;

ARTICLE; BENIGN TUMOR; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALIGNANT NEOPLASTIC DISEASE; MELANOCYTIC NEVUS; MELANOMA; PRIORITY JOURNAL; SKIN CARCINOGENESIS; TUMOR GROWTH;

CELL TRANSFORMATION, NEOPLASTIC; CONNEXIN 43; CONNEXINS; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; NEVUS, PIGMENTED; SKIN NEOPLASMS;

EID: 84890856228     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0b013e318278d401     Document Type: Article

References (26)

1. Kumar NM, Gilula NB. The gap junction communication channel. Cell. 1996;84:381-388.
2. Haass NK, Smalley KS, Herlyn M. The role of altered cell-cell communication in melanoma progression. J Mol Histol. 2004;35:309-318. (Pubitemid 40585316)
3. Pfeffer F, Koczan D, Adam U, et al. Expression of connexin26 in islets of Langerhans is associated with impaired glucose tolerance in patients with pancreatic adenocarcinoma. Pancreas. 2004;29:284-290. (Pubitemid 40228274)
4. Villaret DB, Wang T, Dillon D, et al. Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis. Laryngoscope. 2000;110(pt 1):374-381. (Pubitemid 30143678)
5. Jamieson S, Going JJ, D'Arcy R, et al. Expression of gap junction proteins connexin 26 and connexin 43 in normal human breast and in breast tumours. J Pathol. 1998;184:37-43. (Pubitemid 28086151)
6. Kanczuga-Koda L, Sulkowski S, Lenczewski A, et al. Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer. J Clin Pathol. 2006;59:429-433.
7. Naoi Y, Miyoshi Y, Taguchi T, et al. Connexin26 expression is associated with aggressive phenotype in human papillary and follicular thyroid cancers. Cancer Lett. 2008;262:248-256.
8. Naoi Y, Miyoshi Y, Taguchi T, et al. Connexin26 expression is associated with lymphatic vessel invasion and poor prognosis in human breast cancer. Breast Cancer Res Treat. 2007;106:11-17. (Pubitemid 47498083)
9. Ito A, Koma Y, Uchino K, et al. Increased expression of connexin 26 in the invasive component of lung squamous cell carcinoma: Significant correlation with poor prognosis. Cancer Lett. 2006;234:239- 248.
10. Ezumi K, Yamamoto H, Murata K, et al. Aberrant expression of connexin 26 is associated with lung metastasis of colorectal cancer. Clin Cancer Res. 2008;14:677-684. (Pubitemid 351231147)
11. Zhang W, Nwagwu C, Le DM, et al. Increased invasive capacity of connexin43-overexpressing malignant glioma cells. J Neurosurg. 2003; 99:1039-1046. (Pubitemid 44717400)
12. Han Y, Zhang PJ, Chen T, et al. Connexin43 expression increases in the epithelium and stroma along the colonic neoplastic progression pathway: Implications for its oncogenic role. Gastroenterol Res Pract. 2011;2011:8. Article ID 561719.
13. Umhauer S, Ruch RJ, Fanning J. Gap junctional intercellular communication and connexin 43 expression in ovarian carcinoma. Am J Obstet Gynecol. 2000;182:999-1000. (Pubitemid 30353260)
14. Wilgenbus KK, Kirkpatrick CJ, Knuechel R, et al. Expression of Cx26, Cx32 and Cx43 gap junction proteins in normal and neoplastic human tissues. Int J Cancer. 1992;51:522-529.
15. Jinn Y, Ichioka M, Marumo F. Expression of connexin32 and connexin43 gap junction proteins and E-cadherin in human lung cancer. Cancer Lett. 1998;127:161-169. (Pubitemid 28230800)
16. Mou YY, Zhao GQ, Lin JY, et al. Expression of connexin 43 and E-cadherin in choroidal melanoma. Int J Ophthalmol. 2011;4:156-161.
17. Rezze GG, Fregnani JH, Duprat J, et al. Cell adhesion and communication proteins are differentially expressed in melanoma progression model. Hum Pathol. 2011;42:409-418.
18. Russo G, Zegar C, Giordano A. Advantages and limitations of microarray technology in human cancer. Oncogene. 2003;22:6497-6507. (Pubitemid 37376427)
19. Villares GJ, Dobroff AS, Wang H, et al. Overexpression of proteaseactivated receptor-1 contributes to melanoma metastasis via regulation of connexin 43. Cancer Res. 2009;69:6730-6737.
20. Villares GJ, Zigler M, Bar-Eli M. The emerging role of the thrombin receptor (PAR-1) in melanoma metastasis - a possible therapeutic target. Oncotarget. 2011;2:8-17.
21. Saito-Katsuragi M, Asada H, Niizeki H, et al. Role for connexin 26 in metastasis of human malignant melanoma: Communication between melanoma and endothelial cells via connexin 26. Cancer. 2007;110:1162-1172. (Pubitemid 47312883)
22. el-Sabban ME, Pauli BU. Cytoplasmic dye transfer between metastatic tumor cells and vascular endothelium. J Cell Biol. 1991;115:1375-1382. (Pubitemid 21909981)
23. el-Sabban ME, Pauli BU. Adhesion-mediated gap junctional communication between lung-metastatic cancer cells and endothelium. Invasion Metastasis. 1994;14:164-176.
24. Su YA, BittnerML, Chen Y, et al. Identification of tumor-suppressor genes using human melanoma cell lines UACC903, UACC903(+6), and SRS3 by comparison of expression profiles. Mol Carcinog. 2000;28:119-127. (Pubitemid 30432480)
25. Haass NK, Wladykowski E, Kief S, et al. Differential induction of connexins 26 and 30 in skin tumors and their adjacent epidermis. J Histochem Cytochem. 2006;54:171-182. (Pubitemid 43201638)
26. Haass NK, Ripperger D, Wladykowski E, et al. Melanoma progression exhibits a significant impact on connexin expression patterns in the epidermal tumor microenvironment. Histochem Cell Biol. 2010;133:113-124.